
What smart money is saying about Insmed Incorporated
1 fund in our archive has pitched Insmed Incorporated — most recently Baron Health Care Fund in June 2025.
The Insight Select Income Fund is a closed-end mutual fund, overseen by Cutwater Asset Management Corp., that specializes in fixed income investments within the United States market. Its portfolio primarily consists of both short-term and long-term debt instruments. The fund's investment strategy dictates a focus on high-quality securities, including those rated within the top four grades by Moody's or Standard & Poor's, as well as debt issued by the U.S. Government and various banking institutions. For performance evaluation, the fund utilizes the Lehman Brothers Aggregate Bond TR Index as its benchmark. Established on October 13, 1971, and headquartered in the United States, this fund was previously known as the Cutwater Select Income Fund.
Get an email when a fund writes about it
Fund coverage · 1 thesis
- Baron Health Care FundJune 2025
Insmed Incorporated is a biotechnology company with three leading pulmonology drugs that may generate over $8 billion in peak sales, particularly highlighting the potentially transformative TPIP for pulmonary arterial hypertension and brensocatib for bronchiectasis.
Read the full thesis
Read every full thesis on Insmed Incorporated
Unlock all 1 thesis — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→